Category: Clinical update
New clinical trial launched: the used of stem cells to treat multiple sclerosis
Published on: 17th January 2017A new clinical trial has recently been launched which assesses the use of autologous haematopoietic stem cells, like those found in umbilical cord blood, can be used to treat multiple sclerosis [MS].
MSC from cord tissue used to treat graft-versus-host disease
Published on: 12th January 2015Graft-versus-Host Disease (GvHD) is a common and serious complication that can follow a stem cell transplant from an unrelated donor (non family member). GvHD is divided into acute and chronic forms according to the clinical course and time of the diagnosis. It is a life-threatening condition, which contributes greatly to early mortality after stem cell transplants. Survivors may suffer organ damage and have impaired quality of life.
Rafael Nadal to receive stem cell treatment
Published on: 12th November 2014Rafael Nadal's doctor says the 14-time grand slam winner will receive stem cell treatment on his ailing back.
Hematologic cancers: umbilical cord transplantation
Published on: 10th November 2014John Wagner, one of the most important authorities in the world, publishes new research findings confirming once more that adults with hematoilogic cancers can be treated effectively with a single or a double unit of cord blood.
New method to multiply stem cells makes cord blood even more valuable!
Published on: 29th October 2014Molecular geneticists have discovered a simple way to expand cord blood cells by treating them with a small molecule drug that stimulates their natural proliferation.
Stem cell use in pediatric congenital heart disease trial
Published on: 25th August 2014Mayo Clinic is announcing the first stem cell clinical trial for pediatric congenital heart disease in the United States.
The trial aims to determine how stem cells from autologous umbilical cord blood can help children with hypoplastic left heart syndrome (HLHS).
Video: broadcastmed.com
Our accreditations
